Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.

Amele S, Peters L, Sluzhynska M, Yakovlev A, Scherrer A, Domingo P, Gerstoft J, Viard JP, Gisinger M, Flisiak R, Bhaghani S, Ristola M, Leen C, Jablonowska E, Wandeler G, Stellbrink H, Falconer K, D'Arminio Monforte A, Horban A, Rockstroh JK, Lundgren JD, Mocroft A; EuroSIDA study group.

HIV Med. 2019 Feb 8. doi: 10.1111/hiv.12711. [Epub ahead of print]

PMID:
30734998
2.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations.

Laut KG, Shepherd L, Gottfredsson M, Sedlacek D, Knysz B, Begovac J, Radoi R, Schmied B, Chkhartishvili N, Florence E, Ristola M, Fätkenheuer G, Mulcahy F, Schmid P, Kuzovatova E, Paduta D, Smidt J, Domingo P, Szlávik J, Lundgren J, Mocroft A, Kirk O; EuroSIDA study group.

AIDS. 2018 Nov 28;32(18):2807-2819. doi: 10.1097/QAD.0000000000002035.

PMID:
30289816
3.

Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy.

MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, Kunisaki KM; INSIGHT START Pulmonary Substudy Group.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):e85-e92. doi: 10.1097/QAI.0000000000001797.

PMID:
29985804
4.

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver.

Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Croucher NJ, Hall M, Hillebregt M, Ong SH, Ratmann O, Albert J, Bannert N, Fellay J, Fransen K, Gourlay A, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Cornelissen M, Kellam P, Reiss P, Fraser C; BEEHIVE Collaboration.

Virus Evol. 2018 May 18;4(1):vey007. doi: 10.1093/ve/vey007. eCollection 2018 Jan.

5.

Comprehensive nationwide analysis of mother-to-child HIV transmission in Finland from 1983 to 2013.

Aho I, Kivelä P, Kaijomaa M, Surcel HM, Ristola M, Heikinheimo O, Sutinen J; with the FINHIVPREG Study Team.

Epidemiol Infect. 2018 Jul;146(10):1301-1307. doi: 10.1017/S0950268818001280. Epub 2018 May 15.

PMID:
29759086
6.

Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register.

Tiittala P, Ristola M, Liitsola K, Ollgren J, Koponen P, Surcel HM, Hiltunen-Back E, Davidkin I, Kivelä P.

BMC Infect Dis. 2018 Mar 20;18(1):137. doi: 10.1186/s12879-018-3041-9.

7.

Important Gaps in HIV Knowledge, Attitudes and Practices Among Young Asylum Seekers in Comparison to the General Population.

Tiittala P, Kivelä P, Liitsola K, Ollgren J, Pasanen S, Vasankari T, Ristola M.

J Immigr Minor Health. 2018 Dec;20(6):1415-1423. doi: 10.1007/s10903-018-0707-8.

PMID:
29423620
8.

Optimised PDMS Tunnel Devices on MEAs Increase the Probability of Detecting Electrical Activity from Human Stem Cell-Derived Neuronal Networks.

Toivanen M, Pelkonen A, Mäkinen M, Ylä-Outinen L, Sukki L, Kallio P, Ristola M, Narkilahti S.

Front Neurosci. 2017 Oct 31;11:606. doi: 10.3389/fnins.2017.00606. eCollection 2017.

9.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group.

HIV Med. 2018 Feb;19(2):102-117. doi: 10.1111/hiv.12557. Epub 2017 Oct 6.

10.

Laminin α5 substrates promote survival, network formation and functional development of human pluripotent stem cell-derived neurons in vitro.

Hyysalo A, Ristola M, Mäkinen ME, Häyrynen S, Nykter M, Narkilahti S.

Stem Cell Res. 2017 Oct;24:118-127. doi: 10.1016/j.scr.2017.09.002. Epub 2017 Sep 12.

11.

The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.

Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.

HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31.

PMID:
28857427
12.

Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.

Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, Hall M, Hillebregt M, Ong SH, Albert J, Bannert N, Fellay J, Fransen K, Gourlay AJ, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Vanham G, Berkhout B, Kellam P, Reiss P, Fraser C; BEEHIVE collaboration.

PLoS Biol. 2017 Jul 13;15(7):e1002608. doi: 10.1371/journal.pbio.1002608. eCollection 2017 Jul.

13.

Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.

Achhra AC, Mocroft A, Ross M, Ryom-Nielson L, Avihingsanon A, Bakowska E, Belloso W, Clarke A, Furrer H, Lucas GM, Ristola M, Rassool M, Ross J, Somboonwit C, Sharma S, Wyatt C.

Int J Antimicrob Agents. 2017 Sep;50(3):453-460. doi: 10.1016/j.ijantimicag.2017.04.021. Epub 2017 Jun 28.

14.

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.

Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, Hall M, Hillebregt M, Ong SH, Albert J, Bannert N, Fellay J, Fransen K, Gourlay AJ, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Vanham G, Berkhout B, Kellam P, Reiss P, Fraser C; BEEHIVE collaboration.

PLoS Biol. 2017 Jun 12;15(6):e2001855. doi: 10.1371/journal.pbio.2001855. eCollection 2017 Jun. Erratum in: PLoS Biol. 2017 Jul 13;15(7):e1002608.

15.

Aligned Poly(ε-caprolactone) Nanofibers Guide the Orientation and Migration of Human Pluripotent Stem Cell-Derived Neurons, Astrocytes, and Oligodendrocyte Precursor Cells In Vitro.

Hyysalo A, Ristola M, Joki T, Honkanen M, Vippola M, Narkilahti S.

Macromol Biosci. 2017 Jul;17(7). doi: 10.1002/mabi.201600517. Epub 2017 Mar 15.

PMID:
28296144
16.

Cell culture chamber with gas supply for prolonged recording of human neuronal cells on microelectrode array.

Kreutzer J, Ylä-Outinen L, Mäki AJ, Ristola M, Narkilahti S, Kallio P.

J Neurosci Methods. 2017 Mar 15;280:27-35. doi: 10.1016/j.jneumeth.2017.01.019. Epub 2017 Feb 1.

PMID:
28161299
17.

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.

Llibre JM, Cozzi-Lepri A, Pedersen C, Ristola M, Losso M, Mocroft A, Mitsura V, Falconer K, Maltez F, Beniowski M, Vullo V, Hassoun G, Kuzovatova E, Szlavik J, Kuznetsova A, Stellbrink HJ, Duvivier C, Edwards S, Laut K, Paredes R; EuroSIDA Study.

Medicine (Baltimore). 2016 Oct;95(40):e5020.

18.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J; PARTNER Study Group.

JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148. Erratum in: JAMA. 2016 Aug 9;316(6):667. Erratum in: JAMA. 2016 Nov 15;316(19):2048.

PMID:
27404185
19.

Accuracy of ultrasonography in predicting vesicoureteral reflux in children: A meta-analysis.

Saltychev M, Ristola MT, Laimi K, Hurme T.

Scand J Urol. 2016 Aug;50(4):239-45. doi: 10.1080/21681805.2016.1194462. Epub 2016 Jun 16. Review.

PMID:
27310111
20.

Factors Associated with Abnormal Imaging and Infection Recurrence after a First Febrile Urinary Tract Infection in Children.

Ristola MT, Löyttyniemi E, Hurme T.

Eur J Pediatr Surg. 2017 Apr;27(2):142-149. doi: 10.1055/s-0036-1572418. Epub 2016 Feb 8.

PMID:
26855368
21.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

22.

Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland.

Heikinheimo T, Poutiainen E, Salonen O, Elovaara I, Ristola M.

BMJ Open. 2015 Nov 5;5(11):e007986. doi: 10.1136/bmjopen-2015-007986.

23.

Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States.

Ristola M, Arbeit RD, von Reyn CF, Horsburgh CR Jr.

Biomed Res Int. 2015;2015:713845. doi: 10.1155/2015/713845. Epub 2015 Jun 9.

24.

Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway.

Saurus P, Kuusela S, Lehtonen E, Hyvönen ME, Ristola M, Fogarty CL, Tienari J, Lassenius MI, Forsblom C, Lehto M, Saleem MA, Groop PH, Holthöfer H, Lehtonen S.

Cell Death Dis. 2015 May 7;6:e1752. doi: 10.1038/cddis.2015.125.

25.

Achieving high acceptability of HIV testing in a population-based survey among immigrants in Finland.

Tiittala PJ, Kivelä PS, Ristola MA, Surcel HM, Koponen PM, Mölsä M, Ollgren J, Liitsola K.

Scand J Public Health. 2015 Jun;43(4):393-8. doi: 10.1177/1403494815573604. Epub 2015 Mar 18.

PMID:
25788469
26.

Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Law MG, Achhra A, Deeks SG, Gazzard B, Migueles SA, Novak RM, Ristola M; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:37-45. doi: 10.1111/hiv.12232.

27.

Consequences of following the new American Academy of Pediatrics guidelines for imaging children with urinary tract infection.

Ristola MT, Hurme T.

Scand J Urol. 2015;49(5):419-23. doi: 10.3109/21681805.2015.1009485. Epub 2015 Feb 7.

PMID:
25660228
28.

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression.

Llibre JM, Cozzi-Lepri A, La Rosa JA, Pedersen C, Ristola M, Losso M, Mocroft A, Mitsura VM, Ormaasen V, Maltez F, Beniowski M, Paredes R; Eurosida in Eurocoord.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19810. doi: 10.7448/IAS.17.4.19810. eCollection 2014.

29.

NICE Guidelines Cannot Be Recommended for Imaging Studies in Children Younger Than 3 Years with Urinary Tract Infection.

Ristola MT, Hurme T.

Eur J Pediatr Surg. 2015 Oct;25(5):414-20. doi: 10.1055/s-0034-1384646. Epub 2014 Jul 31.

PMID:
25077594
30.

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.

Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Kirk O; EuroSIDA in EuroCOORD.

Infection. 2014 Aug;42(4):757-62. doi: 10.1007/s15010-014-0630-4. Epub 2014 Jun 6.

31.

Functions of the podocyte proteins nephrin and Neph3 and the transcriptional regulation of their genes.

Ristola M, Lehtonen S.

Clin Sci (Lond). 2014 Mar;126(5):315-28. doi: 10.1042/CS20130258. Review.

PMID:
24219158
32.

Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors.

Søgaard OS, Reekie J, Ristola M, Jevtovic D, Karpov I, Beniowski M, Servitskiy S, Domingo P, Reiss P, Mocroft A, Kirk O.

J Infect. 2013 May;66(5):439-46. doi: 10.1016/j.jinf.2012.12.012. Epub 2013 Jan 24.

PMID:
23353671
33.

NICE guidelines for imaging studies in children with UTI adequate only in boys under the age of 6 months.

Ristola MT, Hurme T.

Pediatr Surg Int. 2013 Mar;29(3):215-22. doi: 10.1007/s00383-012-3257-5. Epub 2013 Jan 13.

PMID:
23314790
34.

Regulation of nephrin gene by the Ets transcription factor, GA-binding protein.

Ristola M, Arpiainen S, Shimokawa T, Ra C, Tienari J, Saleem MA, Holthöfer H, Lehtonen S.

Nephrol Dial Transplant. 2013 Apr;28(4):846-55. doi: 10.1093/ndt/gfs482. Epub 2012 Nov 29.

PMID:
23197680
35.

Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.

Vrouenraets SM, Wit FW, Garcia EF, Huber M, Brinkman K, Moyle G, Domingo P, Tarr PE, Podzamczer D, Ristola M, Gatell JM, Livrozet JM, Furrer H, Reiss P; PREPARE Study Group.

HIV Clin Trials. 2012 Mar-Apr;13(2):103-10. doi: 10.1310/hct1302-103.

PMID:
22510357
36.

[HIV--from a lethal disease to a chronic illness].

Sutinen J, Ristola M.

Duodecim. 2012;128(1):37-46. Review. Finnish.

PMID:
22312826
37.

Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-κB and silenced by DNA methylation.

Ristola M, Arpiainen S, Saleem MA, Holthöfer H, Lehtonen S.

Nephrol Dial Transplant. 2012 May;27(5):1737-45. doi: 10.1093/ndt/gfr576. Epub 2011 Oct 6.

PMID:
21980157
38.

Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy.

Sevastianova K, Sutinen J, Greco D, Sievers M, Salmenkivi K, Perttilä J, Olkkonen VM, Wågsäter D, Lidell ME, Enerbäck S, Eriksson P, Walker UA, Auvinen P, Ristola M, Yki-Järvinen H.

Diabetes. 2011 Jul;60(7):1894-900. doi: 10.2337/db11-0075. Epub 2011 May 20.

39.

A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.

Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O; Eurosida Study Group.

HIV Clin Trials. 2011 Mar-Apr;12(2):109-17. doi: 10.1310/hct1202-109.

PMID:
21498154
40.

Trans-interaction of nephrin and Neph1/Neph3 induces cell adhesion that associates with decreased tyrosine phosphorylation of nephrin.

Heikkilä E, Ristola M, Havana M, Jones N, Holthöfer H, Lehtonen S.

Biochem J. 2011 May 1;435(3):619-28. doi: 10.1042/BJ20101599.

PMID:
21306299
41.

Serodiagnosis of primary infections with human parvovirus 4, Finland.

Lahtinen A, Kivelä P, Hedman L, Kumar A, Kantele A, Lappalainen M, Liitsola K, Ristola M, Delwart E, Sharp C, Simmonds P, Söderlund-Venermo M, Hedman K.

Emerg Infect Dis. 2011 Jan;17(1):79-82. doi: 10.3201/eid1701.100750.

42.

The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study.

Heikinheimo O, Lehtovirta P, Aho I, Ristola M, Paavonen J.

Am J Obstet Gynecol. 2011 Feb;204(2):126.e1-4. doi: 10.1016/j.ajog.2010.09.002. Epub 2010 Oct 29.

PMID:
21035781
43.

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, Shlipak MG, Tracy R, Neaton JD.

J Infect Dis. 2010 Jun 15;201(12):1788-95. doi: 10.1086/652749.

44.

Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005.

Kivelä PS, Krol A, Salminen MO, Ristola MA.

HIV Med. 2010 Jul 1;11(6):360-7. doi: 10.1111/j.1468-1293.2009.00783.x. Epub 2009 Dec 8.

45.

Regulation of Neph3 gene in podocytes--key roles of transcription factors NF-kappaB and Sp1.

Ristola M, Arpiainen S, Saleem MA, Mathieson PW, Welsh GI, Lehtonen S, Holthöfer H.

BMC Mol Biol. 2009 Aug 24;10:83. doi: 10.1186/1471-2199-10-83.

46.

Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.

van Vonderen MG, van Agtmael MA, Hassink EA, Milinkovic A, Brinkman K, Geerlings SE, Ristola M, van Eeden A, Danner SA, Reiss P; MEDICLAS study group.

PLoS One. 2009 May 21;4(5):e5647. doi: 10.1371/journal.pone.0005647.

47.

First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K, Geerlings SE, Sutinen J, Ristola M, Danner SA, Reiss P.

AIDS. 2009 Jul 17;23(11):1367-76. doi: 10.1097/QAD.0b013e32832c4947.

PMID:
19424051
48.

High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.

Kivelä PS, Krol A, Partanen AL, Ristola MA.

Scand J Public Health. 2009 Jun;37(4):357-63. doi: 10.1177/1403494809105290. Epub 2009 Apr 16.

PMID:
19372233
49.

Involvement of intraocular structures in disseminated histoplasmosis.

Ala-Kauhaluoma M, Aho I, Ristola M, Karma A.

Acta Ophthalmol. 2010 Jun;88(4):493-6. doi: 10.1111/j.1755-3768.2008.01454.x. Epub 2009 Dec 24.

50.

Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.

Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Järvinen H.

Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E85-91. doi: 10.1152/ajpendo.90224.2008. Epub 2008 Apr 22.

Supplemental Content

Loading ...
Support Center